Skip to main content
Retour
Watch Compare

Organogenesis Holdings Inc.

Qualité des données : 100%
ORGO
Nasdaq Manufacturing Chemicals
2,30 €
▼ 0,10 € (-3,97%)
Cap. Boursière: 295,23 M
Prix
2,30 €
Cap. Boursière
295,23 M
Fourchette du Jour
2,23 € — 2,43 €
Fourchette 52 Semaines
2,21 € — 7,08 €
Volume
1 406 441
Ouverture 2,40 €
Moyenne 50J / 200J
3,21 €
28,50% below
Moyenne 50J / 200J
4,27 €
46,22% below

Quick Summary

Points Clés

Revenue grew 4,78% annually over 5 years — modest growth
Earnings grew 4201,05% over the past year
ROE of 15,17% — decent returns on equity
Negative free cash flow of -24,46 M
P/E of 7,97 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12,26%

Croissance

Revenue Growth (5Y)
4,78%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)17,04%
Earnings (1Y)4201,05%
FCF Growth (3Y)N/A

Qualité

Return on Equity
15,17%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC8,65%
Net Margin6,56%
Op. Margin7,92%

Sécurité

Debt / Equity
N/A
Current Ratio3,32
Interest Coverage19,59

Valorisation

PE (TTM)
7,97
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio1,16
EV/EBITDA3,86
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 8,0 -1,5
P/B 1,2 1,6
ROE % 15,2 -53,5
Net Margin % 6,6 -41,5
Rev Growth 5Y % 4,8 1,8
D/E — 0,3

ETFs Holding This Stock

VYMBX VYMBX
0,39% weight
VYMYX VYMYX
0,39% weight
VYMRX VYMRX
0,39% weight
VYMVX VYMVX
0,39% weight
VYMSX VYMSX
0,39% weight
VYMQX VYMQX
0,39% weight
TSVAX TSVAX
0,29% weight
PSVDX PSVDX
0,29% weight
PSVKX PSVKX
0,29% weight
TSVRX TSVRX
0,29% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,04% Revenue Growth (3Y) 14,13%
Earnings Growth (1Y) 4201,05% Earnings Growth (3Y) 173,66%
Revenue Growth (5Y) 4,78% Earnings Growth (5Y) -20,96%
Profitability
Revenue (TTM) 564,17 M Net Income (TTM) 37,03 M
ROE 15,17% ROA 7,63%
Gross Margin N/A Operating Margin 7,92%
Net Margin 6,56% Free Cash Flow (TTM) -24,46 M
ROIC 8,65% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,32
Interest Coverage 19,59 Asset Turnover 1,16
Working Capital 209,43 M Tangible Book Value 216,41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 7,97 Forward P/E N/A
P/B Ratio 1,16 P/S Ratio 0,52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 3,86 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,29%
Market Cap 295,23 M Enterprise Value 231,49 M
Per Share
EPS (Diluted TTM) 0,15 Revenue / Share 4,39
FCF / Share -0,19 OCF / Share -0,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) -32,20%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2,51% FCF Conversion -66,05%
SBC-Adj. FCF -36,15 M Growth Momentum 12,26

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 564,17 M 482,04 M 433,14 M 450,89 M 468,06 M
Net Income 37,03 M 861 000,0 4,95 M 15,53 M 94,90 M
EPS (Diluted) 0,15 -0,01 0,04 0,12 0,71
Gross Profit — 366,30 M 326,66 M 345,87 M 353,86 M
Operating Income 44,69 M -1,28 M 12,53 M 22,30 M 72,92 M
EBITDA — — — — —
R&D Expenses 44,54 M 50,27 M 44,38 M 39,76 M 30,74 M
SG&A Expenses 326,24 M 294,51 M 269,75 M 283,81 M 250,20 M
D&A 15,27 M 13,62 M — — —
Interest Expense -2,28 M 1,54 M 2,19 M 2,01 M 7,24 M
Income Tax 9,94 M -3,67 M 5,45 M 4,75 M -31,12 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 598,73 M 497,89 M 460,03 M 449,36 M 443,26 M
Total Liabilities 164,81 M 112,57 M 181,36 M 183,69 M 201,22 M
Shareholders' Equity 300,13 M 262,90 M 278,66 M 265,67 M 242,04 M
Total Debt — — 66,56 M 71,25 M 74,06 M
Cash & Equivalents 93,68 M 135,57 M 103,84 M 102,48 M 113,93 M
Current Assets 362,19 M 285,94 M 225,04 M 222,61 M 226,98 M
Current Liabilities 100,12 M 77,48 M 80,51 M 75,02 M 82,01 M